Igambit Inc (IGMB) 0.0519 $IGMB IGAMBIT Announces Sale

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Igambit Inc (IGMB) 0.0519 $IGMB

IGAMBIT Announces Sale of Gotham Subsidiary
Marketwired - Wed Nov 11, 4:04PM CST
iGambit Inc. (OTCQB: IGMB), a diversified holding company, announced that on November 5, 2015, through its wholly owned subsidiary Gotham Innovation Lab, Inc. ("Gotham" it sold certain assets of the Gotham business to VHT, Inc ("VHT".

iGambit Announces Acquisition of ArcMail, a Leading Provider of Email Management Solutions
Marketwired - Tue Nov 10, 11:02AM CST
iGambit Inc. (OTCQB: IGMB), a diversified holding company, announced that on November 4, 2015 it acquired Wala, Inc doing business as ArcMail Technology (ArcMail) via a stock purchase agreement. ArcMail will operate as a wholly owned subsidiary of iGambit.

iGambit Inc. Retains American Capital Ventures for Investor Relations Services
Marketwired - Tue May 19, 7:01AM CDT
iGambit Inc. (OTCQB: IGMB), a diversified holding company, today is pleased to announce that it has engaged American Capital Ventures ("ACV", a boutique provider of comprehensive investor relations, financial marketing and capital advisory services to the micro- and small-cap community.

iGambit Files Form 8-K, Announces Execution of Letter of Intent to Acquire United Fertility Centers of America
GlobeNewswire - Wed May 13, 2:46PM CDT
iGambit Inc. (OTCQB:IGMB), a diversified holding company, announced that on May 12, 2015 it entered into a Letter of Intent ("LOI" with United Fertility Centers of America (UFCA), which manages specialty outpatient fertility clinics. Pursuant to the LOI, at closing, iGambit will buy all the assets of UFCA and will assume certain specifically identified operating liabilities of UFCA. The assets and liabilities of UFCA will be placed into a new wholly-owned subsidiary of iGambit.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading